Logo Logo
Switch Language to German

Iking-Konert, Christof; Specker, Christof; Krueger, Klaus; Schulze-Koops, Hendrik and Aries, Peer (2021): Aktueller Stand der Impfung gegen SARS-CoV-2. In: Zeitschrift für Rheumatologie, Vol. 80, No. 2: pp. 158-164

Full text not available from 'Open Access LMU'.


On 21 December 2020 the European Medicines Agency (EMA) approved the mRNA vaccine BNT162b2 (Comirnaty (R), BioNTech, Mainz, Germany;Pfizer, New York City, NY, USA) as the first vaccine against SARS-CoV-2 in the European Union and the second vaccine (Moderna (R), Moderna, Cambridge, MA, USA) followed on 6 January 2021. Many more approvals will follow within a short period of time. With the availability of the vaccination many questions have arisen for patients as well as for physicians, which are addressed as up to date as possible in this hot topic article.

Actions (login required)

View Item View Item